YF
MCID: YLL002
MIFTS: 58

Yellow Fever (YF) malady

Categories: Rare diseases, Infectious diseases, Skin diseases

Aliases & Classifications for Yellow Fever

About this section
Sources:
2CDC, 11Disease Ontology, 13DISEASES, 30ICD10, 31ICD10 via Orphanet, 32ICD9CM, 39MeSH, 40MESH via Orphanet, 45NCIt, 48NIH Rare Diseases, 50Novoseek, 54Orphanet, 62SNOMED-CT, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Yellow Fever:

Name: Yellow Fever 11 48 54 50 2 39 13 68
Jungle Yellow Fever 11 68
Urban Yellow Fever 11 68
Yf 48 54
 
Sylvatic Yellow Fever 11
Yellow Fever, Sylvan 11
Bronze John 54
Yellow Jack 54

Characteristics:

Orphanet epidemiological data:

54
yellow fever:
Prevalence: <1/1000000 (Europe); Age of onset: All ages; Age of death: any age

Classifications:



External Ids:

Disease Ontology11 DOID:9682
ICD9CM32 060, 060.9
MeSH39 D015004
NCIt45 C35547
Orphanet54 ORPHA99829
UMLS via Orphanet69 C0043395
MESH via Orphanet40 D015004
ICD10 via Orphanet31 A95.0, A95.1, A95.9

Summaries for Yellow Fever

About this section
Disease Ontology:11 A viral infectious disease that results in infection, has material basis in Yellow fever virus, which is transmitted by Aedes, transmitted by Haemagogus, or transmitted by Sabethes species of mosquitoes. The infection has symptom fever, has symptom muscle pain, has symptom backache, has symptom headache, has symptom shivers, has symptom loss of appetite, has symptom jaundice, and has symptom bleeding from the mouth, nose, eyes or stomach leading to vomitus containing blood.

MalaCards based summary: Yellow Fever, also known as jungle yellow fever, is related to hemorrhagic fever and kyasanur forest disease, and has symptoms including Array, Array and Array. An important gene associated with Yellow Fever is EIF2AK4 (Eukaryotic Translation Initiation Factor 2 Alpha Kinase 4), and among its related pathways are OX40 Pathway and IL-9 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types. Affiliated tissues include liver, skin and kidney, and related mouse phenotypes are liver/biliary system and hematopoietic system.

CDC:2 Yellow fever virus is found in tropical and subtropical areas in South America and Africa. The virus is transmitted to people by the bite of an infected mosquito. Yellow fever is a very rare cause of illness in U.S. travelers. Illness ranges in severity from a self-limited febrile illness to severe liver disease with bleeding. 

Wikipedia:71 Yellow fever is a viral disease of typically short duration. In most cases, symptoms include fever,... more...

Related Diseases for Yellow Fever

About this section

Diseases related to Yellow Fever via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 104)
idRelated DiseaseScoreTop Affiliating Genes
1hemorrhagic fever11.0
2kyasanur forest disease10.7
3eating seizures10.2CCL5, CCR5
4encephalitis10.2
5hypercementosis10.2CCL5, IL5
6hepatitis c virus10.1CCR5, OAS1, RSAD2
7marasmus10.1IL4, IL5
8osteodysplasty precocious of danks mayne and kozlowski10.1CCL5, CCR5, IL4
9cerebral primitive neuroectodermal tumor10.1CCL5, IL4, IL5
10papillary squamous carcinoma10.1IL4, IL5
11retinal ischemia10.1CCL2, CCL5, CCR5
12apricot allergy10.1CCL5, IL4, IL5
13trachea leiomyoma10.1CCL5, IL4, IL5
14visceral steatosis10.1CCL5, IL4, IL5
15cutaneous fibrous histiocytoma10.1CCL5, IL4, IL5
16smooth muscle tumor10.1CCL2, CCL5, IL5
17bone peripheral neuroepithelioma10.1IL4, IL5, SCP2
18ethmoid sinusitis10.1CCL5, IL4, IL5
19indian plum allergy10.1IL4, IL5, SCP2
20inflamed seborrheic keratosis10.1CCL5, IL4, IL5
21lens-induced iridocyclitis10.1IL4, IL5
22patellar tendinitis10.1CCL5, IL4, IL5
23pulmonary tuberculosis10.1CCL5, IL4, IL5
24spastic paraplegia 3a, autosomal dominant10.0IL4, IL5
25spontaneous ocular nystagmus10.0CCL5, IL4, IL5
26paratyphoid fever10.0IL4, IL5, SCP2
27lipid storage disease10.0CCL5, IL4, IL5
28thelaziasis10.0IL4, IL5
29lymphoblastic leukemia10.0IL4, IL5
30malignant peritoneal solitary fibrous tumor10.0CCL5, IL4, IL5
31membranoproliferative glomerulonephritis10.0CCR5, IL4, IL5
32plantar fasciitis10.0CCL2, CCL5, CCR5, RSAD2
33rectum squamous cell carcinoma10.0CCL2, CCL5, IL5
34hepatitis10.0
35st. louis encephalitis10.0
36measles10.0
37status epilepticus10.0CCL2, CCL5, IL4
38proximal symphalangism10.0CCL2, CCR5, IL4
39urethral intrinsic sphincter deficiency10.0CCL2, IL4, IL5
40hypersensitivity vasculitis10.0IL4, IL5
41neonatal jaundice10.0CCL2, CCL5, IL4
42pigmentation disease10.0CCL2, CCL5, IL4
43mediastinum neurofibroma10.0CCL5, IL4, IL5, SCP2
44nervous system cancer10.0CCL2, CCL5, IL4
45malaria10.0
46hyperimmunoglobulin syndrome10.0CCL2, CCL5, STAT1
47chikungunya9.9
48japanese encephalitis9.9
49egg allergy9.9
50neuronitis9.9

Graphical network of the top 20 diseases related to Yellow Fever:



Diseases related to yellow fever

Symptoms & Phenotypes for Yellow Fever

About this section

Symptoms:

 11 (show all 8)
  • fever
  • muscle pain
  • backache
  • headache
  • shivers
  • loss of appetite
  • jaundice
  • bleeding from the mouth

Human phenotypes related to Yellow Fever:

 54 64 (show all 29)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 renal insufficiency64 54 Occasional (29-5%) HP:0000083
2 proteinuria64 54 Frequent (79-30%) HP:0000093
3 nephropathy64 54 Occasional (29-5%) HP:0000112
4 photophobia64 54 Occasional (29-5%) HP:0000613
5 jaundice64 54 Frequent (79-30%) HP:0000952
6 lethargy64 54 Occasional (29-5%) HP:0001254
7 meningitis64 54 Occasional (29-5%) HP:0001287
8 congestive heart failure64 54 Occasional (29-5%) HP:0001635
9 dehydration64 54 Occasional (29-5%) HP:0001944
10 fever64 54 Very frequent (99-80%) HP:0001945
11 diarrhea64 54 Frequent (79-30%) HP:0002014
12 nausea and vomiting64 54 Frequent (79-30%) HP:0002017
13 abdominal pain64 54 Frequent (79-30%) HP:0002027
14 anorexia64 54 Frequent (79-30%) HP:0002039
15 hypothermia64 54 Occasional (29-5%) HP:0002045
16 malignant hyperthermia64 54 Occasional (29-5%) HP:0002047
17 gastrointestinal hemorrhage64 54 Frequent (79-30%) HP:0002239
18 headache64 54 Very frequent (99-80%) HP:0002315
19 encephalitis64 54 Occasional (29-5%) HP:0002383
20 hypotension64 54 Occasional (29-5%) HP:0002615
21 arthralgia64 54 Frequent (79-30%) HP:0002829
22 myalgia64 54 Frequent (79-30%) HP:0003326
23 spontaneous abortion64 54 Frequent (79-30%) HP:0005268
24 cardiorespiratory arrest64 54 Occasional (29-5%) HP:0006543
25 acute hepatic failure64 54 Occasional (29-5%) HP:0006554
26 arrhythmia64 54 Occasional (29-5%) HP:0011675
27 oliguria64 54 Frequent (79-30%) HP:0100520
28 chest pain64 54 Frequent (79-30%) HP:0100749
29 menometrorrhagia64 54 Frequent (79-30%) HP:0400008

MGI Mouse Phenotypes related to Yellow Fever according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053707.3CCR5, EIF2AK4, FGA, IL4, IL5, SCP2
2MP:00053977.1CCL5, CCR5, EIF2AK4, FGA, IL1RL1, IL4
3MP:00053767.1CCR5, EIF2AK4, F10, FGA, IL4, IL5
4MP:00053876.2CCL2, CCL5, CCR5, EIF2AK4, FGA, IL1RL1

Drugs & Therapeutics for Yellow Fever

About this section

Drugs for Yellow Fever (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 64)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1VaccinesPhase 4, Phase 3, Phase 2, Phase 16611
2
Vitamin Aapproved, nutraceutical, vet_approvedPhase 349211103-57-4, 68-26-8445354
Synonyms:
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
11103-57-4
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
A-Mulsal
A-Sol
A-Vi-Pel
A-Vitan
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
AR-1L3057
ATAV
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
All Trans Retinol
All-trans retinol
All-trans-Retinol
Alphalin
Alphasterol
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A Parenteral
Aquasynth
Atars
Avibon
Avita
Avitol
Axerol
Axerophthol
Axerophtholum
BIDD:PXR0102
BRN 0403040
Bentavit A
Biosterol
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
CID445354
Chocola A
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
HMS1921B04
HMS2092L13
HMS501I08
HSDB 815
Hi-A-Vita
Homagenets Aoral
Homagenets aorl
Hydrovit A
IDI1_000486
LMPR01090001
LPK
LS-1578
Lard Factor
M.V.C. 9+3
M.V.I.-12
 
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
NSC 122759
NSC122759
Nio-A-Let
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
Retinol
Retinol [INN:BAN]
Retinol solution
Retinol, all-trans- (8CI)
Retinol-(cellular-retinol-binding-protein)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
SMP2_000102
SMR000112036
SPECTRUM1501203
ST057232
Sehkraft A
Solu-A
Spectrum5_000993
Spectrum5_001997
Super A
Testavol
Testavol S
Thalasphere
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-Alpha
Vi-Dom-A
Vi-a
Vio-A
Vitamin A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin A alcohol (VAN)
Vitamin A cryst
Vitamin A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin- A
Vitamin- A alcohol
Vitamin- A alcohol solution
Vitamin- A1
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
Wachstumsvitamin
ZINC03831417
Zinosan N
[11,12-3H]-Retinol
alin
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-Retinol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
all-trans-retinol
all-trans-retinyl alcohol
all-trans-vitamin A alcohol
b-Retinol
beta-Retinol
retinol
tROL
trans-Retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
trans-retinol
3VitaminsPhase 35282
4
LactitolPhase 3336585-86-43871
Synonyms:
4-O-b-D-Galactopyranosyl-D-glucitol, 9CI
E966
Emportal
 
Floralac
Importal
Oponaf
Portolac
5Heptavalent Pneumococcal Conjugate VaccinePhase 3, Phase 2465
6Trace ElementsPhase 36001
7Retinol palmitatePhase 3492
8MicronutrientsPhase 36001
9Protective AgentsPhase 37443
10AntioxidantsPhase 33050
11Pharmaceutical SolutionsPhase 38192
12KrestinPhase 3210
13retinolNutraceuticalPhase 3492
14
BenzocaineapprovedPhase 1, Phase 220161994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
15tannic acidapproved, NutraceuticalPhase 1, Phase 22016
16AntimetabolitesPhase 212054
17AntibodiesPhase 2, Phase 16394
18ImmunoglobulinsPhase 2, Phase 16394
19Antiviral AgentsPhase 29967
20Lipid Regulating AgentsPhase 22766
21Hypolipidemic AgentsPhase 22785
22Hydroxymethylglutaryl-CoA Reductase InhibitorsPhase 21998
23Anti-Inflammatory AgentsPhase 2, Phase 110729
24Anticholesteremic AgentsPhase 22025
25
Mannitolapproved, investigationalPhase 128069-65-8453, 6251
Synonyms:
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexol
(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
(L)-Mannitol
1,2,3,4,5,6-Hexanehexol
123897-58-5
133-43-7
15719_ALDRICH
15719_RIEDEL
33440_RIEDEL
33440_SIGMA
36413-61-3
4-01-00-02841 (Beilstein Handbook Reference)
5149-40-6
63559_FLUKA
63559_SIGMA
63560_FLUKA
63565_FLUKA
63565_SIGMA
69-65-8
75398-80-0
85085-15-0
87-78-5
AB1002081
AC-12776
AC1L1M49
AC1Q28E5
AI3-19511
AR-1J3861
Ambap69-65-8
BRN 1721898
C00392
C6H14O6
CCRIS 369
CHEBI:16899
CHEMBL689
CID6251
Cordycepate
Cordycepic acid
D-(-)-Mannitol
D-Mannitol
D-Mannitol (JP15)
D-mannite
D-mannitol
D00062
D008353
DL-Mannitol
Diosmol
ED1D1E61-FEFB-430A-AFDC-D1F4A957FC3D
EINECS 200-711-8
EINECS 201-770-2
Fraxinine
HSDB 714
Hexahydroxyhexane
Hexanhexol
Invenex
Isotol
LS-1588
LS-89250
M0044
M1902_SIGMA
M4125_SIAL
M8429_SIAL
M9546_SIAL
M9647_SIAL
MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER
MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%
 
MANNITOL 25%
MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%
MLS001335977
MLS001335978
MTL
Manicol
Manitol
Maniton S
Maniton-S
Manna Sugar
Manna sugar
Mannazucker
Mannidex
Mannidex 16700
Mannigen
Mannistol
Mannit
Mannit p
Mannite
Mannitol
Mannitol (USP)
Mannitol (VAN)
Mannitol 10%
Mannitol 10% In Plastic Container
Mannitol 15%
Mannitol 15% In Plastic Container
Mannitol 20%
Mannitol 20% In Plastic Container
Mannitol 5%
Mannitol 5% In Plastic Container
Mannitol [USAN]
Mannitolum
Mannogem 2080
Marine Crystal
Marine crystal
MolPort-003-927-039
Mushroom sugar
NCGC00164246-01
NCI-C50362
NSC 407017
NSC 9256
OSMITROL 10% IN WATER IN PLASTIC CONTAINER
OSMITROL 15% IN WATER IN PLASTIC CONTAINER
OSMITROL 20% IN WATER IN PLASTIC CONTAINER
OSMITROL 5% IN WATER IN PLASTIC CONTAINER
Osmitrol
Osmitrol (TN)
Osmitrol 10% In Water
Osmitrol 15% In Water
Osmitrol 20% In Water
Osmitrol 5% In Water
Osmofundin
Osmosal
Resectisol
Resectisol In Plastic Container
SDM No. 35
SMR000857324
SORBITOL-MANNITOL IN PLASTIC CONTAINER
Sorbitol-Mannitol
TL806434
UNII-3OWL53L36A
ZINC02041302
bmse000099
cpd without stereochemical designation
e 421
e-421
e421
manita
mannitol
26
LenograstimapprovedPhase 11220135968-09-1
Synonyms:
G-CSF (CHO cell derived)
Glycosylated recombinant G-CSF
Glycosylated recombinant granulocyte colony stimulating factor
 
Granulocyte colony stimulating factor 3 (CHO cell derived)
Granulocyte colony-stimulating factor lenograstim
Lenograstim (genetical recombination)
Lenograstim rDNA
27
Dexamethasoneapproved, investigational, vet_approvedPhase 1217150-02-25743
Synonyms:
(3H)-Dexamethasone
.delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol
.gamma.corten
1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone
1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone
1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
137098-19-2
16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone
16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone
16-alpha-Methyl-9-alpha-fluoroprednisolone
16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol
16.alpha.-Methyl-9.alpha.-fluoroprednisolone
16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol
16alpha -Methyl-9alpha -fluoroprednisolone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone
16alpha-Methyl-9alpha-fluoroprednisolone
16α-Methyl-9α-fluoro-1-dehydrocortisol
23495-06-9
31375_FLUKA
46165_FLUKA
46165_RIEDEL
50-02-2
8054-59-9
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione
9-Fluoro-16-methylprednisolone
9-alpha-Fluoro-16-alpha-methylprednisolone
9.alpha.-Fluoro-16.alpha.-methylprednisolone
906422-84-2
9A-FLUORO-16BETA-METHYLPREDNISOLONE
9alpha -Fluoro-16alpha -methylprednisolone
9alpha-Fluoro-16alpha-methylprednisolone
9alpha-fluoro-16alpha-methyl-Prednisolone
9α-Fluoro-16α-methylprednisolone
AC-11056
AC1L1L1H
AC1Q29DM
AI3-50934
Adexone
Aeroseb-D
Aeroseb-Dex
Aeroseb-dex
Ak Dex Oph Otic Soln 0.1%
Alcon Brand of Dexamethasone
Anaflogistico
Aphtasolon
Aphthasolone
Apo-dexamethasone
Auxiron
Azimycin (veterinary)
Azium
Azium (Veterinary)
Azium (veterinary)
BIDD:ER0494
BIDD:PXR0060
BRD-K38775274-001-02-3
BRD-K38775274-001-06-4
BSPBio_000995
Bisu DS
Bisu Ds
C15643
C22H29FO5
CCRIS 7067
CHEBI:41879
CHEMBL384467
CID5743
CPD-10549
CPD001227192
Calonat
Corson
Corsone
Cortisumman
D00292
D003907
D1756_SIGMA
D4902_SIGMA
D6645_SIGMA
D8893_SIGMA
D9184_SIGMA
DB01234
DEX
DEXA
DEXONE 0.5
DEXONE 0.75
DEXONE 1.5
DEXONE 4
DXM
DXMS
Decacort
Decacortin
Decaderm
Decadron
Decadron (TN)
Decadron Tablets, Elixir
Decadron, Dexamethasone
Decadron-LA
Decadron-La
Decagel
Decaject
Decaject L.A.
Decaject-L.A.
Decalix
Decameth
Decasone
Decaspray
Dectancyl
Dekacort
Delta1-9alpha-Fluoro-16alpha-methylcortisol
Deltafluorene
Dergramin
Deronil
Desadrene
Desametasone
Desametasone [DCIT]
Desametasone [Dcit]
Desamethasone
Desameton
Deseronil
Dex-Ide
Dex-ide
Dexa
Dexa Mamallet
Dexa mamallet
Dexa-Cortidelt
Dexa-Cortisyl
Dexa-Mamallet
Dexa-Scheroson
Dexa-Sine
Dexa-cortidelt
Dexa-cortisyl
Dexa-scheroson
Dexa-sine
Dexacen-4
Dexacidin
Dexacort
Dexacortal
Dexacortin
Dexadeltone
Dexafarma
Dexair
Dexalona
Dexaltin
Dexametasona
Dexametasona [INN-Spanish]
Dexametasone
 
Dexameth
Dexamethansone
Dexamethasone
Dexamethasone (JP15/USP/INN)
Dexamethasone Acetate
Dexamethasone Alcohol
Dexamethasone Base
Dexamethasone Intensol
Dexamethasone Sodium Phosphate
Dexamethasone [INN:BAN:JAN]
Dexamethasone alcohol
Dexamethasone base
Dexamethasone intensol
Dexamethasone-omega
Dexamethasonum
Dexamethasonum [INN-Latin]
Dexamethazone
Dexamonozon
Dexapolcort
Dexapos
Dexaprol
Dexason
Dexasone
Dexasone 0.5mg
Dexasone 0.75mg
Dexasone 4mg
Dexasporin
Dexinolon
Dexinoral
Dexone
Dexone 0.5
Dexone 0.75
Dexone 1.5
Dexone 4
Dexonium
Dexpak
Dextelan
Dezone
Dinormon
Dxms
ECR Brand of Dexamethasone
EINECS 200-003-9
FT-0080377
Fluormethylprednisolone
Fluormone
Fluorocort
Fortecortin
Foy Brand of Dexamethasone
Gammacorten
HL-dex
HMS1792A17
HMS1990A17
HMS2089N13
HSDB 3053
Hexadecadrol
Hexadrol
Hexadrol Elixir
Hexadrol Tablets
Hexadrol elixir
Hl-Dex
Hl-dex
I06-1196
ICN Brand of Dexamethasone
IontoDex
Isopto-Dex
Isopto-dex
LS-7300
Lokalison F
Lokalison f
Loverine
Luxazone
MK 125
MLS001055412
MLS001332507
MLS001332508
Maxidex
Maxidex Ont 0.1%
Maxidex Sus 0.1%
Maxitrol
Mediamethasone
Merck Brand of Dexamethasone
Merz Brand 1 of Dexamethasone
Merz Brand 2 of Dexamethasone
Methylfluorprednisolone
Mexidex
Millicorten
MolMap_000018
MolPort-003-846-433
Mymethasone
NCGC00091019-01
NCGC00091019-02
NCGC00091019-03
NCGC00091019-04
NCGC00091019-05
NCI60_003067
NSC 34521
NSC34521
Naquasone (veterinary)
Neomycin and polymyxin b sulfates and dexamethasone
Neomycin and polymyxin b sulphates and dexamethasone
OTO-104
Ocu-Trol
Ocu-trol
Oradexon
PHL-dexamethasone
PMS-dexamethasone
Pet Derm III
Pet Derm Iii
Pet derm III
Pet-Derm Iii
Pms Dexamethasone Elixir 0.5mg/5ml
Policort
Posurdex
Prednisolon F
Prednisolon f
Prednisolone F
Prednisolone f
Prodex
S1322_Selleck
SAM002548948
SGCUT00126
SK-Dexamethasone
SK-dexamethasone
SMP1_000092
SMR000857119
SMR001227192
ST50307091
Sandoz dexamethasone
Sk-Dexamethasone
Spectrum5_002019
Spoloven
Sunia Sol D
Sunia sol D
Superprednol
TL8003317
Tobradex
Tobramycin and dexamethasone
Tresaderm (veterinary)
Turbinaire
UNII-7S5I7G3JQL
Visumetazone
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1
ZINC03875332
alpha -Fluoro-16-alpha -methylcortisol
delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta1-9alpha-Fluoro-16alpha-methylcortisol
dexamethasone
nchembio809-comp2
to_000038
28
Aluminum hydroxideapprovedPhase 121021645-51-2
Synonyms:
Al(OH)3
Aluminium hydroxide
Aluminium hydroxide gel, dried
 
Aluminium hydroxide, dried
Aluminum hydroxide gel, dried
Aluminum hydroxide, dried
Dried aluminium hydroxide
Dried aluminum hydroxide gel
29gamma-GlobulinsPhase 1326
30Immunoglobulins, IntravenousPhase 1333
31Aluminum sulfatePhase 192
32Rho(D) Immune GlobulinPhase 1326
33HIV Protease InhibitorsPhase 15470
34glucocorticoidsPhase 15103
35Hormone AntagonistsPhase 113180
36HormonesPhase 114415
37Peripheral Nervous System AgentsPhase 123689
38Gastrointestinal AgentsPhase 18402
39diureticsPhase 11418
40
protease inhibitorsPhase 15471
Synonyms:
 
protease inhibitors
41Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 113168
42AntiemeticsPhase 14022
43Adjuvants, ImmunologicPhase 12554
44Dexamethasone acetatePhase 121711177-87-3
45Antineoplastic Agents, HormonalPhase 15592
46Natriuretic AgentsPhase 11697
47Dexamethasone 21-phosphatePhase 12171
48BB 1101Phase 12171
49Autonomic AgentsPhase 110150
50
Methotrexateapproved15511959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
 
Methopterin
Methotextrate
Methotrate
Methotrexat
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Rheumatrex
Trexall

Interventional clinical trials:

(show all 45)
idNameStatusNCT IDPhase
1IPV Clinical Trial - The GambiaCompletedNCT01847872Phase 4
2Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in MaliCompletedNCT02286895Phase 4
3Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)RecruitingNCT02555072Phase 4
4Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE)Not yet recruitingNCT02991495Phase 4
5Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected IndividualsNot yet recruitingNCT03132311Phase 4
6Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy ToddlersCompletedNCT01436396Phase 3
7A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in AdultsCompletedNCT01466387Phase 3
8Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)CompletedNCT01345240Phase 3
9Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.RecruitingNCT02699099Phase 3
10The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.Active, not recruitingNCT01426243Phase 3
11Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP DeficiencyNot yet recruitingNCT03113760Phase 3
12Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)CompletedNCT00982137Phase 2
13Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever VaccineCompletedNCT01488890Phase 2
14The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in HumansCompletedNCT01943305Phase 2
15Immune Response to Yellow Fever Vaccination in Adults With Atopic DermatitisCompletedNCT00723489Phase 1, Phase 2
16Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI RegimenCompletedNCT00436007Phase 2
17Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 YearsCompletedNCT00788151Phase 2
18Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult SubjectsCompletedNCT00730288Phase 2
19Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & InfantsCompletedNCT01262872Phase 2
20Efficacy of Favipiravir Against Ebola (JIKI)CompletedNCT02329054Phase 2
21Yellow Fever Vaccine on Statin/ Non Statin SubjectsRecruitingNCT03116802Phase 2
22Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the SemenRecruitingNCT02739477Phase 2
23Trial of Yellow Fever Inactivated VaccineCompletedNCT00995865Phase 1
24Yellow Fever Virus Vaccine and Immune Globulin StudyCompletedNCT00254826Phase 1
25Phase I Study of West Nile Virus VaccineCompletedNCT00300417Phase 1
26A Phase I Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy VolunteersRecruitingNCT02743455Phase 1
27A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects.RecruitingNCT02963909Phase 1
28Improving White Blood Cell Collection From Healthy DonorsRecruitingNCT01553214Phase 1
29Yellow Fever Vaccination Under Low Dose Methotrexate TherapyUnknown statusNCT02383680
30Immunity After Two Doses of Yellow Fever VaccineCompletedNCT02572518
31Characterization of T Cell Responses Following Yellow Fever Virus Vaccination in Healthy AdultsCompletedNCT00616356
32Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever VaccinesCompletedNCT01765413
33The Effect of Extended Yellow Fever Vaccine Information on Symptom Reports Following VaccinationCompletedNCT00708630
34Seroprevalence and Incidence of Lassa Fever in the Rural Commune of Sibirila, District of Bougouni, MaliCompletedNCT02311387
35Evaluation of the Safety & Performance of 2 Intradermal Safety DevicesCompletedNCT02556047
36Study to Evaluate the Incidence, Clinical Characteristics and Economic Burden of Dengue in Brazilian ChildrenCompletedNCT01391819
37The Interaction Between Measles and DTP VaccinationCompletedNCT02710045
38A Trial Comparing the Uncovered to the Covered Wallstent in the Palliation of Malignant Bile Duct StricturesCompletedNCT01047332
39A Clinical Trial to Evaluate the Effectiveness and Safety of Chinese Medicine in the Treatment of Mild Type of Hand, Foot, and Mouth DiseaseCompletedNCT01182532
40Turnover of Antigen Specific Lymphocytes After Immunization With the Yellow Fever VaccineRecruitingNCT01290055
41Human Immune Responses to The Yellow Fever Virus VaccineRecruitingNCT00694655
42Immune Responses to Yellow Fever VaccineRecruitingNCT01244802
43Cohort of Patients Infected by an ArbovirusRecruitingNCT01099852
44Vaccines Immunogenicity in Renal, Hepatic, Cardiac or Pulmonary Transplanted ChildrenRecruitingNCT03180359
45Complementary Study of the Duration of Post-vaccination Against Yellow Fever Immunity in ChildrenActive, not recruitingNCT02990182

Search NIH Clinical Center for Yellow Fever


Cochrane evidence based reviews: yellow fever

Genetic Tests for Yellow Fever

About this section

Anatomical Context for Yellow Fever

About this section

MalaCards organs/tissues related to Yellow Fever:

36
Liver, Skin, Kidney, Eye, T cells, Heart, Nk cells

Publications for Yellow Fever

About this section

Articles related to Yellow Fever:

(show top 50)    (show all 660)
idTitleAuthorsYear
1
Reemergence of yellow fever in Ethiopia after 50A years, 2013: epidemiological and entomological investigations. (28506254)
2017
2
Importation of yellow fever into China: assessing travel patterns. (28426111)
2017
3
Identification and initial characterization of matrix metalloproteinases in the yellow fever mosquito, Aedes aegypti. (28054419)
2017
4
Yellow Fever Virus Modulates the Expression of Key Proteins Related to the microRNA Pathway in the Human Hepatocarcinoma Cell Line HepG2. (28388330)
2017
5
Adaptive Diversification between Yellow Fever Virus West African and South American Lineages: A Genome-Wide Study. (28044043)
2017
6
Autochthonous Japanese Encephalitis with Yellow Fever Coinfection in Africa. (28402771)
2017
7
Yellow fever from Angola and Congo: a storm gathers. (28424031)
2017
8
Max Theiler (1899-1972): Creator of the yellow fever vaccine. (28429035)
2017
9
Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017. (28472025)
2017
10
Heparin removal by ecteola-cellulose pre-treatment enables the use of plasma samples for accurate measurement of anti-Yellow fever virus neutralizing antibodies. (28514646)
2017
11
The Yellow Fever Vaccine Misadventure of 1942. (28492447)
2017
12
T Cell-Mediated Immunity towards Yellow Fever Virus and Useful Animal Models. (28398253)
2017
13
Efficacy of Some Wearable Devices Compared with Spray-On Insect Repellents for the Yellow Fever Mosquito, Aedes aegypti (L.) (Diptera: Culicidae). (28423421)
2017
14
What to expect from the 2017 yellow fever outbreak in Brazil? (28423092)
2017
15
Yellow fever in the Americas: the growing concern about new epidemics. (28529708)
2017
16
Yellow Fever Outbreak - Kongo Central Province, Democratic Republic of the Congo, August 2016. (28358796)
2017
17
Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease. (28366605)
2017
18
Eliminate Yellow fever Epidemics (EYE): a global strategy, 2017a892026. (28429585)
2017
19
Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults. (28380113)
2017
20
Adaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccination. (28386132)
2017
21
Notes from the Field: Adverse Events Following a Mass Yellow Fever Immunization Campaign - Kongo Central Province, Democratic Republic of the Congo, September 2016. (28358792)
2017
22
Thiosemicarbazones and Phthalyl-Thiazoles compounds exert antiviral activity against yellow fever virus and Saint Louis encephalitis virus. (28068627)
2017
23
Narcolepsy Following Yellow Fever Vaccination: A Case Report. (27559330)
2016
24
Reining in Angola's yellow fever outbreak. (27843160)
2016
25
Safety of yellow fever vaccine in Indian travellers: A prospective observational study. (28361832)
2016
26
Yellow fever virus capsid protein is a potent suppressor of RNA silencing that binds double-stranded RNA. (27849599)
2016
27
Yellow fever vaccine supply: a possible solution. (27116054)
2016
28
Yellow fever: a global reckoning. (27115797)
2016
29
Is Sri Lanka prepared for yellow fever outbreaks? A case study. (27855869)
2016
30
INFECTIOUS DISEASES. Yellow fever outbreak triggers vaccine alarm. (27124428)
2016
31
Frequency of histopathological changes in Howler monkeys ( Alouatta sp.) naturally infected with yellow fever virus in Brazil. (27163561)
2016
32
Fractional dosing of yellow fever vaccine to extend supply: a modelling study. (27837923)
2016
33
Animal models of yellow fever and their application in clinical research. (27093699)
2016
34
Comparative study of adverse events after yellow fever vaccination between elderly and non-elderly travellers: questionnaire survey in Japan over a 1-year period. (27021495)
2016
35
Yellow fever outbreaks in SALo Paulo State, Brazil, 2000-2010. (27869924)
2016
36
Yellow fever vaccination during treatment with infliximab in a patient with ulcerative colitis: A case report. (27612222)
2016
37
Chaperone-Assisted Protein Folding Is Critical for Yellow Fever Virus NS3/4A Cleavage and Replication. (26739057)
2016
38
Yellow fever vaccine: worthy friend or stealthy foe? (27087465)
2016
39
Why is the yellow fever outbreak in Angola a 'threat to the entire world'? (27163382)
2016
40
International Health Regulations in practice: Focus on yellow fever and poliomyelitis. (27541082)
2016
41
Vigilance still needed to contain Africa's yellow fever outbreak, says WHO. (27586155)
2016
42
Yellow fever in Africa: a disaster waiting to happen. (27477983)
2016
43
Contrasting female-male mortality ratios after routine vaccinations with pentavalent vaccine versus measles and yellow fever vaccine. A cohort study from urban Guinea-Bissau. (27475473)
2016
44
Modelling a way out of yellow fever. (27837922)
2016
45
A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein. (27654301)
2016
46
First case of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) in Hong Kong. (27087559)
2016
47
Another pandemic disaster looms: yellow fever spreading from Angola. (27642446)
2016
48
Inadvertent yellow fever vaccination of a patient with Crohn's disease treated with infliximab and methotrexate. (27571912)
2016
49
The 17D-204 Vaccine Strain-Induced Protection against Virulent Yellow Fever Virus Is Mediated by Humoral Immunity and CD4+ but not CD8+ T Cells. (27463517)
2016
50
A Meta-Analysis of Serological Response Associated with Yellow Fever Vaccination. (27928091)
2016

Variations for Yellow Fever

About this section

Expression for genes affiliated with Yellow Fever

About this section
Search GEO for disease gene expression data for Yellow Fever.

Pathways for genes affiliated with Yellow Fever

About this section

Pathways related to Yellow Fever according to GeneCards Suite gene sharing:

(show all 22)
idSuper pathwaysScoreTop Affiliating Genes
19.6IL4, IL5
29.6IL4, IL5
39.3CCL2, STAT1
4
Show member pathways
9.3CCL2, CCL5, CCR5
5
Show member pathways
9.2IRF7, OAS1, STAT1
69.2IL1RL1, IL4, IL5
79.2IL1RL1, IL4, IL5
89.0IL4, IL5, STAT1
99.0EIF2AK4, IRF7, OAS1, STAT1
10
Show member pathways
9.0CCR5, IL4, STAT1
11
Show member pathways
9.0IRF7, OAS1, RSAD2, STAT1
128.8CCL2, IL4, STAT1
138.8CCL2, CCL5, IL4, IL5
148.8CCL2, CCL5, IL4, IL5
158.8CCL2, CCL5, CCR5, IL4
16
Show member pathways
8.1IL4, IL5, IRF7, OAS1, RSAD2, STAT1
17
Show member pathways
8.0CCL2, CCL5, IL1RL1, IRF7, OAS1, STAT1
18
Show member pathways
7.8CCL2, CCL5, CCR5, IL4, IL5, STAT1
197.6CCL2, CCL5, IL4, IRF7, OAS1, RSAD2
20
Show member pathways
7.4CCL2, CCL5, EIF2AK4, IL4, IRF7, OAS1
21
Show member pathways
5.7CCL2, CCL5, CCR5, FGA, IL1RL1, IL4
22
Show member pathways
5.7CCL2, CCL5, CCR5, FGA, IL1RL1, IL4

GO Terms for genes affiliated with Yellow Fever

About this section

Cellular components related to Yellow Fever according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098979.1CCR5, FGA, IL1RL1, IL4
2extracellular regionGO:00055766.8CCL2, CCL5, F10, FGA, IL1RL1, IL4

Biological processes related to Yellow Fever according to GeneCards Suite gene sharing:

(show all 24)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of macrophage apoptotic processGO:200011010.6CCL5, IRF7
2dendritic cell chemotaxisGO:000240710.6CCL5, CCR5
3positive regulation of JAK-STAT cascadeGO:004642710.5CCL5, IL5
4positive regulation of defense response to virus by hostGO:000223010.4EIF2AK4, IL4
5macrophage chemotaxisGO:004824610.4CCL2, CCL5
6positive regulation of macrophage chemotaxisGO:001075910.3CCL2, CCL5
7positive regulation of monocyte chemotaxisGO:009002610.3CCL2, CCL5
8response to tumor necrosis factorGO:003461210.3CCL2, CCL5
9negative regulation of viral genome replicationGO:004507110.2CCL5, OAS1, RSAD2
10cellular protein complex assemblyGO:004362310.1CCL5, FGA
11chemokine-mediated signaling pathwayGO:007009810.0CCL2, CCL5, CCR5
12cytokine-mediated signaling pathwayGO:001922110.0CCL2, IL1RL1, IL5
13interferon-gamma-mediated signaling pathwayGO:00603339.9IRF7, OAS1, STAT1
14response to virusGO:00096159.9CCL5, IRF7, OAS1, RSAD2
15negative regulation of endothelial cell apoptotic processGO:20003529.8FGA, IL4
16response to cytokineGO:00340979.7CCL5, IL4, STAT1
17inflammatory responseGO:00069549.7CCL2, CCL5, CCR5, IL5
18MAPK cascadeGO:00001659.6CCL2, CCL5, CCR5, IL5
19type I interferon signaling pathwayGO:00603379.6IRF7, OAS1, RSAD2, STAT1
20chemotaxisGO:00069359.5CCL2, CCL5, CCR5, IL4
21defense response to virusGO:00516079.5EIF2AK4, IRF7, OAS1, RSAD2, STAT1
22immune system processGO:00023769.2EIF2AK4, FGA, IRF7, OAS1, RSAD2
23viral processGO:00160328.7CCR5, EIF2AK4, IRF7, RSAD2, STAT1
24immune responseGO:00069558.4CCL2, CCL5, CCR5, IL1RL1, IL4, IL5

Molecular functions related to Yellow Fever according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1phosphatidylinositol phospholipase C activityGO:00044359.8CCL5, CCR5
2cytokine activityGO:00051259.2CCL2, CCL5, IL4, IL5

Sources for Yellow Fever

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet